In total, 48 NSCLC samples (55.8%) showed strong CIRP expression, while 21 NSCLC samples (24.4%) and 17 NSCLC samples (19.8%) showed moderate and weak CIRP expression, respectively. This evidence concerns the gene CIRBP and non-small cell lung carcinoma.